Author:
Zohar Joseph,Nutt David J.,Kupfer David J.,Moller Hans-Jurgen,Yamawaki Shigeto,Spedding Michael,Stahl Stephen M.
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology
Reference13 articles.
1. Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia;Alberati;Neuropharmacology,2012
2. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder;Bang-Andersen;J. Med. Chem.,2011
3. Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study;Bauer;J. Clin. Psychiatry,2009
4. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study;Berman;J. Clin. Psychiatry,2007
5. Partial occupancy of the glycine transporter type 1 in monkey by RG1678 leads to efficacy in a model of prefrontal cortical function;Borroni;Schizophr. Bull.,2011
Cited by
87 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献